Infographic - Children with Depression

Depression in children under age 12 is a serious mental health concern that can have lifelong consequences. Parents and healthcare professionals often feel torn between the risks and benefits of antidepressant medications in young patients, but the evidence shows that these medications can be life-changing when used thoughtfully.

Prozac (Fluoxetine): The Only FDA-Approved Antidepressant for Depression Under Age 12
Among all antidepressants, fluoxetine (Prozac) is currently the only medication approved by the U.S. Food and Drug Administration (FDA) for treating major depressive disorder in children under the age of 12. This indication by the FDA was granted in 2003.  This means that we are currently at 22+ years without an additional medication option.

Other antidepressants, while not FDA-approved for depression in this age group, have also been studied:

• Zoloft (sertraline): 2 positive studies under age 12
• Celexa (citalopram): 1 positive study under age 12
• Paxil (paroxetine): 3 negative studies
• Lexapro (escitalopram): 1 negative study

These results indicate that while Prozac leads the way, other medications may provide significant benefit. Working with a child psychiatrist to understand the research and the many options is important.  Note that Lexapro is FDA approved for depression between the ages of 12-17.  It is the only other antidepressant FDA approved younger than age 18. Other options are certainly used off-label, but selection of an alternative is very nuanced.  

How Effective Are Antidepressants in Children?
The effectiveness of antidepressants is very encouraging, especially when combined with therapy. A notable study involving adolescents with moderate to severe depression found that after 36 weeks an impressive 86% of participants receiving both an antidepressant and cognitive behavioral therapy (CBT) responded to treatment. This combination remains the gold standard for improving mood, functioning, and preventing relapse in children.

Suicide Risk: What the Numbers Really Say
One of the most discussed concerns around antidepressant use in children is the risk of suicidal thoughts or behaviors. It is crucial to interpret this data accurately.

• The lifetime prevalence of a suicide attempt among depressed adolescents is approximately 4.1%.
• No single antidepressant has an adjusted relative risk above 1.0 for suicide attempts. This means that no medication has been shown to increase the overall risk of a suicide attempt when statistical adjustments are made. The study that supported this data had over 35,000 youth enrolled.
• Suicide attempts rose in the general population after the 2004 FDA black box warning was added to antidepressants. The warning led to a sharp drop in prescriptions, and many patients who needed treatment discontinued their medications. This correlated with a spike in suicide attempts and hospitalizations. This paradox highlights a critical point. Untreated depression is far more dangerous than properly monitored antidepressant use.

Long-Term Risks of Untreated Depression
Beyond short-term mood symptoms, depression in childhood can have long-term consequences. One study found that early-onset depression in males was associated with a significantly increased risk of never having children later in life. This suggests potential lifelong impairments in relationships and functioning when mood disorders go untreated.

What If the First Medication Doesn’t Work?
It’s relatively common for the first antidepressant to be partially effective or even ineffective. One high-quality study looked at teens who didn’t respond to their initial SSRI and found no statistically significant difference in response rates when switching to either a second SSRI or to venlafaxine (Effexor). This means that both options are reasonable, and decisions can be based on side effect profiles, patient history, and other factors.

A Positive Outlook on Medication for Depression
Antidepressants are not a cure-all, but they are one of the most powerful tools we have to treat depression in children and adolescents. When used correctly, they can improve quality of life, reduce symptoms, and prevent long-term complications. It’s essential to monitor side effects and assess risks carefully. The larger truth is that the risks of untreated depression often outweigh the risks of treatment. With careful evaluation and compassionate care, children struggling with depression can thrive, and antidepressants can help them get there, especially when used in combination with talk therapy.

If you are a parent or guardian and believe your child may be experiencing depression, please reach out to a local child psychiatrist for an evaluation.